Basal cell carcinoma risk factors: Difference between revisions
Jump to navigation
Jump to search
(20 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Basal cell carcinoma}} | {{Basal cell carcinoma}} | ||
{{CMG}} {{AE}} Saarah T. Alkhairy, M.D. | {{CMG}} {{AE}}{{M.N}}, Saarah T. Alkhairy, M.D. | ||
==Overview== | ==Overview== | ||
Environmental and [[genetic]] [[risk factors]] that may predispose to basal cell carcinoma include [[radiation exposure]], physical characteristics, gender, [[albinism]], [[xeroderma pigmentosum]], epidermodysplastic verruciformis, [[nevoid basal cell carcinoma syndrome]], [[bazex syndrome]], rombo syndrome etc. | |||
==Basal Cell Carcinoma Risk Factors== | ==Basal Cell Carcinoma Risk Factors== | ||
There are some environmental and genetic risk factors that may predispose to basal cell carcinoma.<ref name="CameronLee2019">{{cite journal|last1=Cameron|first1=Michael C.|last2=Lee|first2=Erica|last3=Hibler|first3=Brian P.|last4=Barker|first4=Christopher A.|last5=Mori|first5=Shoko|last6=Cordova|first6=Miguel|last7=Nehal|first7=Kishwer S.|last8=Rossi|first8=Anthony M.|title=Basal cell carcinoma|journal=Journal of the American Academy of Dermatology|volume=80|issue=2|year=2019|pages=303–317|issn=01909622|doi=10.1016/j.jaad.2018.03.060}}</ref> | *There are some [[Environmental Health Perspectives|environmental]] and [[genetic]] [[risk factors]] that may predispose to basal cell carcinoma.<ref name="CameronLee2019">{{cite journal|last1=Cameron|first1=Michael C.|last2=Lee|first2=Erica|last3=Hibler|first3=Brian P.|last4=Barker|first4=Christopher A.|last5=Mori|first5=Shoko|last6=Cordova|first6=Miguel|last7=Nehal|first7=Kishwer S.|last8=Rossi|first8=Anthony M.|title=Basal cell carcinoma|journal=Journal of the American Academy of Dermatology|volume=80|issue=2|year=2019|pages=303–317|issn=01909622|doi=10.1016/j.jaad.2018.03.060}}</ref><ref name="pmid21965847">{{cite journal |vauthors=Hallaji Z, Rahimi H, Mirshams-Shahshahani M |title=Comparison of risk factors of single Basal cell carcinoma with multiple Basal cell carcinomas |journal=Indian J Dermatol |volume=56 |issue=4 |pages=398–402 |date=July 2011 |pmid=21965847 |pmc=3179002 |doi=10.4103/0019-5154.84766 |url=}}</ref><ref name="pmid14525881">{{cite journal |vauthors=Wong CS, Strange RC, Lear JT |title=Basal cell carcinoma |journal=BMJ |volume=327 |issue=7418 |pages=794–8 |date=October 2003 |pmid=14525881 |pmc=214105 |doi=10.1136/bmj.327.7418.794 |url=}}</ref> | ||
The following table summarizes the causes of basal cell carcinoma (BCC): | *The following table summarizes the [[causes]] of basal cell carcinoma (BCC): | ||
{| {{table}} | {| {{table}} cellpadding="4" cellspacing="0" style="border:#c9c9c9 1px solid; margin: 1em 1em 1em 0; border-collapse: collapse;" | ||
| align="center" style="background:# | | align="center" style="background: #4479BA;" | {{fontcolor|#FFF|'''Risk factor'''}} | ||
| align="center" style="background: #4479BA;" | {{fontcolor|#FFF|'''Description'''}} | |||
|- | |- | ||
| '''Radiation exposure'''||Sunlight (UV light), tanning | | '''Radiation exposure'''||[[Sunlight]] ([[UV light]]), [[Tanning booths|tanning bed]]<nowiki/>s, and [[x-rays]] exposure are associated with basal cell carcinoma formation<ref name="pmid15737190">{{cite journal| author=Lim JL, Stern RS| title=High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. | journal=J Invest Dermatol | year= 2005 | volume= 124 | issue= 3 | pages= 505-13 | pmid=15737190 | doi=10.1111/j.0022-202X.2005.23618.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15737190}}</ref> | ||
|- | |- | ||
| '''Physical features'''||Red/blonde hair, blue/green eyes, freckling, and skin types I and II (skin that always burns and never/only sometimes tans) are associated with an increased risk for basal cell carcinoma | | '''Physical features'''||Red/blonde [[hair]], [[blue]]/green [[eyes]], [[Freckles|freckling]], and [[skin]] types I and II ([[skin]] that always [[burns]] and never/only sometimes tans) are associated with an increased risk for basal cell carcinoma | ||
|- | |- | ||
| '''Albinism'''||[[Albinism]] is associated with an increased risk for basal cell carcinoma | | '''Albinism'''||[[Albinism]] is associated with an increased risk for basal cell carcinoma | ||
|- | |- | ||
| '''Gender'''||The male gender is associated with an increased risk for basal cell carcinoma | | '''Gender'''||The [[male]] gender is associated with an increased risk for basal cell carcinoma | ||
|- | |- | ||
| '''Xeroderma pigmentosum'''||This an [[autosomal recessive]] disorder; it results in the inability to repair ultraviolet-induced DNA damage; pigmentary changes are seen early in life, followed by the development of basal cell carcinoma, [[squamous cell carcinoma]], and [[malignant melanoma]]; other features include corneal opacities, eventual blindness, and neurological deficits | | '''Xeroderma pigmentosum'''||This an [[autosomal recessive]] disorder; it results in the inability to repair [[Ultraviolet light|ultraviolet]]-induced [[DNA damage]]; pigmentary changes are seen early in [[life]], followed by the [[development]] of basal cell carcinoma, [[squamous cell carcinoma]], and [[malignant melanoma]]; other features include [[corneal]] opacities, eventual [[blindness]], and [[neurological]] deficits | ||
|- | |- | ||
| '''Epidermodysplastic verruciformis'''||Epidermodysplastic verruciformis is an autosomal recessive disorder characterized by the development of basal cell carcinoma and squamous cell carcinoma from warts ([[human papillomavirus]] infection)<ref name="pmid15149508">{{cite journal| author=Harwood CA, Surentheran T, Sasieni P, Proby CM, Bordea C, Leigh IM et al.| title=Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. | journal=Br J Dermatol | year= 2004 | volume= 150 | issue= 5 | pages= 949-57 | pmid=15149508 | doi=10.1111/j.1365-2133.2004.05847.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15149508 }} </ref> | | '''Epidermodysplastic verruciformis'''||Epidermodysplastic verruciformis is an [[autosomal recessive disorder]] characterized by the [[development]] of basal cell carcinoma and [[squamous cell carcinoma]] from [[warts]] ([[human papillomavirus]] infection)<ref name="pmid15149508">{{cite journal| author=Harwood CA, Surentheran T, Sasieni P, Proby CM, Bordea C, Leigh IM et al.| title=Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. | journal=Br J Dermatol | year= 2004 | volume= 150 | issue= 5 | pages= 949-57 | pmid=15149508 | doi=10.1111/j.1365-2133.2004.05847.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15149508 }} </ref> | ||
|- | |- | ||
| '''Nevoid basal cell carcinoma syndrome'''||This is an [[autosomal dominant]] disorder that can result in basal cell carcinomas, multiple odontogenic keratocysts, palmoplantar pitting, [[intracranial calcification]], and rib anomalies<ref name="pmid10355946">{{cite journal| author=Cohen MM| title=Nevoid basal cell carcinoma syndrome: molecular biology and new hypotheses. | journal=Int J Oral Maxillofac Surg | year= 1999 | volume= 28 | issue= 3 | pages= 216-23 | pmid=10355946 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10355946}}</ref> | | '''Nevoid basal cell carcinoma syndrome'''||This is an [[autosomal dominant]] disorder that can result in basal cell carcinomas, multiple [[Odontogenic keratocyst|odontogenic keratocysts]], palmoplantar pitting, [[intracranial calcification]], and [[rib]] anomalies<ref name="pmid10355946">{{cite journal| author=Cohen MM| title=Nevoid basal cell carcinoma syndrome: molecular biology and new hypotheses. | journal=Int J Oral Maxillofac Surg | year= 1999 | volume= 28 | issue= 3 | pages= 216-23 | pmid=10355946 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10355946}}</ref> | ||
|- | |- | ||
| '''Bazex Syndrome'''||The features of Bazex syndrome include follicular atrophoderma, multiple basal cell carcinomas, and | | '''Bazex Syndrome'''||The features of [[Bazex syndrome]] include follicular atrophoderma, multiple basal cell carcinomas, and [[anhidrosis|local anhidrosis]]<ref>Centers for Disease Control and Prevention (CDC). Sunburn prevalence among adults--United States, 1999, 2003, and 2004. MMWR Morb Mortal Wkly Rep. 2007 Jun 1. 56(21):524-8</ref> | ||
|- | |- | ||
| '''Rombo syndrome'''||Rombo syndrome is an [[autosomal dominant]] condition distinguished by basal cell carcinoma and atrophoderma vermiculatum, trichoepitheliomas, [[hypotrichosis]] milia, and peripheral [[vasodilation]] with [[cyanosis]]<ref name="pmid6177160">{{cite journal| author=Michaëlsson G, Olsson E, Westermark P| title=The Rombo syndrome: a familial disorder with vermiculate atrophoderma, milia, hypotrichosis, trichoepitheliomas, basal cell carcinomas and peripheral vasodilation with cyanosis. | journal=Acta Derm Venereol | year= 1981 | volume= 61 | issue= 6 | pages= 497-503 | pmid=6177160 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6177160 }} </ref> | | '''Rombo syndrome'''||Rombo syndrome is an [[autosomal dominant]] condition distinguished by basal cell carcinoma and atrophoderma vermiculatum, trichoepitheliomas, [[hypotrichosis]] [[milia]], and peripheral [[vasodilation]] with [[cyanosis]]<ref name="pmid6177160">{{cite journal| author=Michaëlsson G, Olsson E, Westermark P| title=The Rombo syndrome: a familial disorder with vermiculate atrophoderma, milia, hypotrichosis, trichoepitheliomas, basal cell carcinomas and peripheral vasodilation with cyanosis. | journal=Acta Derm Venereol | year= 1981 | volume= 61 | issue= 6 | pages= 497-503 | pmid=6177160 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6177160 }} </ref> | ||
|} | |} | ||
Other risk factors for the development of basal cell carcinoma are the following<ref name="CameronLee2019">{{cite journal|last1=Cameron|first1=Michael C.|last2=Lee|first2=Erica|last3=Hibler|first3=Brian P.|last4=Barker|first4=Christopher A.|last5=Mori|first5=Shoko|last6=Cordova|first6=Miguel|last7=Nehal|first7=Kishwer S.|last8=Rossi|first8=Anthony M.|title=Basal cell carcinoma|journal=Journal of the American Academy of Dermatology|volume=80|issue=2|year=2019|pages=303–317|issn=01909622|doi=10.1016/j.jaad.2018.03.060}}</ref> | *Other [[risk factors]] for the [[development]] of basal cell carcinoma are the following<ref name="CameronLee2019">{{cite journal|last1=Cameron|first1=Michael C.|last2=Lee|first2=Erica|last3=Hibler|first3=Brian P.|last4=Barker|first4=Christopher A.|last5=Mori|first5=Shoko|last6=Cordova|first6=Miguel|last7=Nehal|first7=Kishwer S.|last8=Rossi|first8=Anthony M.|title=Basal cell carcinoma|journal=Journal of the American Academy of Dermatology|volume=80|issue=2|year=2019|pages=303–317|issn=01909622|doi=10.1016/j.jaad.2018.03.060}}</ref><ref name="pmid21965847">{{cite journal |vauthors=Hallaji Z, Rahimi H, Mirshams-Shahshahani M |title=Comparison of risk factors of single Basal cell carcinoma with multiple Basal cell carcinomas |journal=Indian J Dermatol |volume=56 |issue=4 |pages=398–402 |date=July 2011 |pmid=21965847 |pmc=3179002 |doi=10.4103/0019-5154.84766 |url=}}</ref>: | ||
<ref> | **Current [[immunosuppressive therapy]] after [[organ transplantation]] | ||
*Current immunosuppressive therapy after organ transplantation | **[[Arsenic]] exposure for a long time | ||
*Personal history of skin cancer | **Personal history of [[skin cancer]] | ||
*Two or more first-degree relatives with [[melanoma]] | **Two or more first-degree relatives with [[melanoma]] | ||
*Total of 100 nevi or at least five atypical (dysplastic) [[nevi]] | **Total of 100 [[nevi]] or at least five atypical (dysplastic) [[nevi]] | ||
*More than 250 treatments with psoralen plus ultraviolet A (UVA) therapy for [[psoriasis]] | **More than 250 [[treatments]] with [[psoralen]] plus ultraviolet A ([[UVA]]) therapy for [[psoriasis]] | ||
*Radiation therapy for cancer as a child | **[[Radiation therapy]] for [[Cancer (medicine)|cancer]] as a [[child]] | ||
*Oral contraceptive pills intake | **[[Oral contraceptive pills]] intake | ||
*Rheumatoid arthritis is also associated with increased risk for basal cell cancer | **[[Rheumatoid arthritis]] is also associated with increased risk for basal cell cancer | ||
==References== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Surgery]] | [[Category:Surgery]] |
Latest revision as of 18:16, 4 April 2019
Basal cell carcinoma Microchapters |
Diagnosis |
---|
Case Studies |
Basal cell carcinoma risk factors On the Web |
American Roentgen Ray Society Images of Basal cell carcinoma risk factors |
Risk calculators and risk factors for Basal cell carcinoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2], Saarah T. Alkhairy, M.D.
Overview
Environmental and genetic risk factors that may predispose to basal cell carcinoma include radiation exposure, physical characteristics, gender, albinism, xeroderma pigmentosum, epidermodysplastic verruciformis, nevoid basal cell carcinoma syndrome, bazex syndrome, rombo syndrome etc.
Basal Cell Carcinoma Risk Factors
- There are some environmental and genetic risk factors that may predispose to basal cell carcinoma.[1][2][3]
- The following table summarizes the causes of basal cell carcinoma (BCC):
Risk factor | Description |
Radiation exposure | Sunlight (UV light), tanning beds, and x-rays exposure are associated with basal cell carcinoma formation[4] |
Physical features | Red/blonde hair, blue/green eyes, freckling, and skin types I and II (skin that always burns and never/only sometimes tans) are associated with an increased risk for basal cell carcinoma |
Albinism | Albinism is associated with an increased risk for basal cell carcinoma |
Gender | The male gender is associated with an increased risk for basal cell carcinoma |
Xeroderma pigmentosum | This an autosomal recessive disorder; it results in the inability to repair ultraviolet-induced DNA damage; pigmentary changes are seen early in life, followed by the development of basal cell carcinoma, squamous cell carcinoma, and malignant melanoma; other features include corneal opacities, eventual blindness, and neurological deficits |
Epidermodysplastic verruciformis | Epidermodysplastic verruciformis is an autosomal recessive disorder characterized by the development of basal cell carcinoma and squamous cell carcinoma from warts (human papillomavirus infection)[5] |
Nevoid basal cell carcinoma syndrome | This is an autosomal dominant disorder that can result in basal cell carcinomas, multiple odontogenic keratocysts, palmoplantar pitting, intracranial calcification, and rib anomalies[6] |
Bazex Syndrome | The features of Bazex syndrome include follicular atrophoderma, multiple basal cell carcinomas, and local anhidrosis[7] |
Rombo syndrome | Rombo syndrome is an autosomal dominant condition distinguished by basal cell carcinoma and atrophoderma vermiculatum, trichoepitheliomas, hypotrichosis milia, and peripheral vasodilation with cyanosis[8] |
- Other risk factors for the development of basal cell carcinoma are the following[1][2]:
- Current immunosuppressive therapy after organ transplantation
- Arsenic exposure for a long time
- Personal history of skin cancer
- Two or more first-degree relatives with melanoma
- Total of 100 nevi or at least five atypical (dysplastic) nevi
- More than 250 treatments with psoralen plus ultraviolet A (UVA) therapy for psoriasis
- Radiation therapy for cancer as a child
- Oral contraceptive pills intake
- Rheumatoid arthritis is also associated with increased risk for basal cell cancer
References
- ↑ 1.0 1.1 Cameron, Michael C.; Lee, Erica; Hibler, Brian P.; Barker, Christopher A.; Mori, Shoko; Cordova, Miguel; Nehal, Kishwer S.; Rossi, Anthony M. (2019). "Basal cell carcinoma". Journal of the American Academy of Dermatology. 80 (2): 303–317. doi:10.1016/j.jaad.2018.03.060. ISSN 0190-9622.
- ↑ 2.0 2.1 Hallaji Z, Rahimi H, Mirshams-Shahshahani M (July 2011). "Comparison of risk factors of single Basal cell carcinoma with multiple Basal cell carcinomas". Indian J Dermatol. 56 (4): 398–402. doi:10.4103/0019-5154.84766. PMC 3179002. PMID 21965847.
- ↑ Wong CS, Strange RC, Lear JT (October 2003). "Basal cell carcinoma". BMJ. 327 (7418): 794–8. doi:10.1136/bmj.327.7418.794. PMC 214105. PMID 14525881.
- ↑ Lim JL, Stern RS (2005). "High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients". J Invest Dermatol. 124 (3): 505–13. doi:10.1111/j.0022-202X.2005.23618.x. PMID 15737190.
- ↑ Harwood CA, Surentheran T, Sasieni P, Proby CM, Bordea C, Leigh IM; et al. (2004). "Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin". Br J Dermatol. 150 (5): 949–57. doi:10.1111/j.1365-2133.2004.05847.x. PMID 15149508.
- ↑ Cohen MM (1999). "Nevoid basal cell carcinoma syndrome: molecular biology and new hypotheses". Int J Oral Maxillofac Surg. 28 (3): 216–23. PMID 10355946.
- ↑ Centers for Disease Control and Prevention (CDC). Sunburn prevalence among adults--United States, 1999, 2003, and 2004. MMWR Morb Mortal Wkly Rep. 2007 Jun 1. 56(21):524-8
- ↑ Michaëlsson G, Olsson E, Westermark P (1981). "The Rombo syndrome: a familial disorder with vermiculate atrophoderma, milia, hypotrichosis, trichoepitheliomas, basal cell carcinomas and peripheral vasodilation with cyanosis". Acta Derm Venereol. 61 (6): 497–503. PMID 6177160.